Galectin Therapeutics Inc/ US3632252025 /
| 2024-08-30 4:55:07 PM | Chg. -0.1900 | Volume | Bid5:00:21 PM | Ask5:00:21 PM | High | Low |
|---|---|---|---|---|---|---|
| 2.5500USD | -6.93% | 96,738 Turnover: 237,896.6436 |
2.5600Bid Size: 100 | 2.5700Ask Size: 100 | 2.7903 | 2.5500 |
GlobeNewswire
08-13
Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2024 and Provides Bus...
GlobeNewswire
06-04
Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2024 ...
GlobeNewswire
05-15
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2024 and Provides Bu...
GlobeNewswire
05-13
Galectin Therapeutics to Participate in the H.C. Wainwright BioConnect Conference
GlobeNewswire
04-09
Galectin Therapeutics Reports the Positive Outcome of the Fifth Data and Safety Monitoring Board Mee...
GlobeNewswire
03-29
Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update
GlobeNewswire
03-12
Galectin Therapeutics Expands Clinical Team with the Appointment of Khurram Jamil, M.D. as Vice Pres...
GlobeNewswire
2023-11-13
UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 an...
GlobeNewswire
2023-11-13
Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provide...
GlobeNewswire
2023-11-03
Galectin Therapeutics to Share Five Scientific Presentations at The Liver Meeting™ 2023, Hosted by t...
GlobeNewswire
2023-10-23
Galectin Therapeutics to Participate in the H.C. Wainwright 7th Annual NASH Investor Conference on O...
GlobeNewswire
2023-10-12
Galectin Therapeutics Announces Nomination of Dr. Benjamin S. Carson, Sr. to Board of Directors
GlobeNewswire
2023-10-03
Galectin Therapeutics Reports the Positive Outcome of the Fourth Data and Safety Monitoring Board Me...
GlobeNewswire
2023-09-26
Galectin Therapeutics to Present Update on its Belapectin Liver Cirrhosis Program at the 20th Editio...
GlobeNewswire
2023-09-11
Galectin Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference...
GlobeNewswire
2023-09-07
Galectin Therapeutics to Present Data on Liver Cirrhosis at the 9th Edition of the Paris NASH meetin...
GlobeNewswire
2022-01-06
Galectin Therapeutics to Present at the H.C. Wainwright BioConnect Conference
GlobeNewswire
2021-12-21
Galectin Therapeutics Announces Closing of $10 Million in Debt Financing from Its Chairman, Richard ...
GlobeNewswire
2021-12-13
Galectin Therapeutics Discusses Corporate Transformation, Progress of NAVIGATE Trial and Outlines St...
GlobeNewswire
2021-11-15
Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2021, and Provid...
GlobeNewswire
2021-11-05
UPDATE – Galectin Therapeutics to Present Six Scientific Abstracts at The Liver Meeting™ 2021, Hoste...
GlobeNewswire
2021-10-27
Galectin Pharmaceuticals to Present Six Scientific Abstracts at The Liver Meeting™ 2021, Hosted by t...
GlobeNewswire
2021-10-05
UPDATE: Galectin Therapeutics to Participate in the H.C. Wainwright 5th Annual NASH Investor Confere...
GlobeNewswire
2021-10-05
Galectin Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
